Patents Assigned to 858 THERAPEUTICS, INC. - Justia Patents Search

Patents Assigned to 858 THERAPEUTICS, INC.

Substituted imidazo[1,2-a]quinazolines and imidazo [1,2-a]pyrido[4,3-e]pyrimidines as inhibitors of PARG

Patent number: 11939335

Abstract: Provided herein are inhibitors of PARG, pharmaceutical compositions comprising the inhibitory compounds, and methods for using the PARG inhibitory compounds for the treatment of disease.

Type: Grant

Filed: May 19, 2023

Date of Patent: March 26, 2024

Assignee: 858 THERAPEUTICS, INC.

Inventors: James M. Veal, Jeffrey A. Stafford, Donald S. Karanewsky, Shyama Herath